Kurt Fernstrom
Examiner (ID: 5518, Phone: (571)272-4422 , Office: P/3711 )
Most Active Art Unit | 3711 |
Art Unit(s) | 3714, 3712, 3715, 3711 |
Total Applications | 2669 |
Issued Applications | 1756 |
Pending Applications | 157 |
Abandoned Applications | 755 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7487378
[patent_doc_number] => 20110251102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'HIGH THROUGHPUT SCREENING OF ION CHANNELS'
[patent_app_type] => utility
[patent_app_number] => 12/757499
[patent_app_country] => US
[patent_app_date] => 2010-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10333
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251102.pdf
[firstpage_image] =>[orig_patent_app_number] => 12757499
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/757499 | High throughput screening of ion channels | Apr 8, 2010 | Issued |
Array
(
[id] => 10614870
[patent_doc_number] => 09334304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Self-assembling peptides bearing organic electronic functionality and applications employing the same'
[patent_app_type] => utility
[patent_app_number] => 13/262742
[patent_app_country] => US
[patent_app_date] => 2010-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 19676
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262742
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/262742 | Self-assembling peptides bearing organic electronic functionality and applications employing the same | Apr 1, 2010 | Issued |
Array
(
[id] => 7754505
[patent_doc_number] => 20120027703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'NOVEL PROTEASOME-ACTIVATING ANTI-AGING PEPTIDES AND COMPOSITIONS CONTAINING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/262481
[patent_app_country] => US
[patent_app_date] => 2010-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5892
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027703.pdf
[firstpage_image] =>[orig_patent_app_number] => 13262481
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/262481 | Proteasome-activating anti-aging peptides and compositions containing same | Mar 31, 2010 | Issued |
Array
(
[id] => 6270913
[patent_doc_number] => 20100255011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING THE ACTIVITY OF COMPLEMENT REGULATORY PROTEINS ON TARGET CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/751943
[patent_app_country] => US
[patent_app_date] => 2010-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 44574
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20100255011.pdf
[firstpage_image] =>[orig_patent_app_number] => 12751943
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/751943 | Compositions and methods for modulating the activity of complement regulatory proteins on target cells | Mar 30, 2010 | Issued |
Array
(
[id] => 7742389
[patent_doc_number] => 20120021020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'BRANCHED AMPHIPATHIC OLIGO-PEPTIDES THAT SELF-ASSEMBLE INTO VESICLES'
[patent_app_type] => utility
[patent_app_number] => 13/259771
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9309
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20120021020.pdf
[firstpage_image] =>[orig_patent_app_number] => 13259771
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/259771 | Branched amphipathic oligo-peptides that self-assemble into vesicles | Mar 25, 2010 | Issued |
Array
(
[id] => 9020445
[patent_doc_number] => 08530431
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-10
[patent_title] => 'Treatment of cancers with immunostimulatory HIV TAT derivative polypeptides'
[patent_app_type] => utility
[patent_app_number] => 12/730043
[patent_app_country] => US
[patent_app_date] => 2010-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 9841
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12730043
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/730043 | Treatment of cancers with immunostimulatory HIV TAT derivative polypeptides | Mar 22, 2010 | Issued |
Array
(
[id] => 7767852
[patent_doc_number] => 20120035108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'SPRAY BASE MATERIAL INCLUDING LOW-MOLECULAR GELATOR'
[patent_app_type] => utility
[patent_app_number] => 13/256765
[patent_app_country] => US
[patent_app_date] => 2010-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14159
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20120035108.pdf
[firstpage_image] =>[orig_patent_app_number] => 13256765
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/256765 | Spray base material including low-molecular gelator | Mar 11, 2010 | Issued |
Array
(
[id] => 8160657
[patent_doc_number] => 20120101253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'STRUCTURED POLYCYCLIC PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 13/147308
[patent_app_country] => US
[patent_app_date] => 2010-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13194
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20120101253.pdf
[firstpage_image] =>[orig_patent_app_number] => 13147308
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/147308 | STRUCTURED POLYCYCLIC PEPTIDE | Feb 3, 2010 | Abandoned |
Array
(
[id] => 6329361
[patent_doc_number] => 20100197890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Anti-cancer protein-platinum conjugates'
[patent_app_type] => utility
[patent_app_number] => 12/657906
[patent_app_country] => US
[patent_app_date] => 2010-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7412
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197890.pdf
[firstpage_image] =>[orig_patent_app_number] => 12657906
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/657906 | Anti-cancer protein-platinum conjugates | Jan 28, 2010 | Abandoned |
Array
(
[id] => 6464913
[patent_doc_number] => 20100190691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'DELIVERY OF NUCLEIC ACIDS USING CELL-PENETRATING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/694122
[patent_app_country] => US
[patent_app_date] => 2010-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10518
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190691.pdf
[firstpage_image] =>[orig_patent_app_number] => 12694122
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/694122 | DELIVERY OF NUCLEIC ACIDS USING CELL-PENETRATING PEPTIDES | Jan 25, 2010 | Abandoned |
Array
(
[id] => 7790521
[patent_doc_number] => 20120052077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'THERAPEUTIC MODULATION OF VAGINAL EPITHELIUM BOUNDARY LUBRICATION'
[patent_app_type] => utility
[patent_app_number] => 13/144203
[patent_app_country] => US
[patent_app_date] => 2010-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8008
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20120052077.pdf
[firstpage_image] =>[orig_patent_app_number] => 13144203
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/144203 | Therapeutic modulation of vaginal epithelium boundary lubrication | Jan 12, 2010 | Issued |
Array
(
[id] => 6387706
[patent_doc_number] => 20100317595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'COMPOSITIONS FOR ENHANCING NAIL GROWTH'
[patent_app_type] => utility
[patent_app_number] => 12/683841
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26216
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317595.pdf
[firstpage_image] =>[orig_patent_app_number] => 12683841
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/683841 | COMPOSITIONS FOR ENHANCING NAIL GROWTH | Jan 6, 2010 | Abandoned |
Array
(
[id] => 6637111
[patent_doc_number] => 20100173837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'DOSING FORMS AND REGIMENS COMPRISING 3-[(R)-2-(N,N-DIMETHYLAMINO)ETHYLTHIO-SAR]-4-(GAMMAHYDROXYMETHYLLEUCINE)CYCLOSPORINE'
[patent_app_type] => utility
[patent_app_number] => 12/683662
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10502
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173837.pdf
[firstpage_image] =>[orig_patent_app_number] => 12683662
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/683662 | DOSING FORMS AND REGIMENS COMPRISING 3-[(R)-2-(N,N-DIMETHYLAMINO)ETHYLTHIO-SAR]-4-(GAMMAHYDROXYMETHYLLEUCINE)CYCLOSPORINE | Jan 6, 2010 | Abandoned |
Array
(
[id] => 6642470
[patent_doc_number] => 20100174351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'CHEMICALLY AND BIOLOGICALLY MODIFIED MEDICAL DEVICES'
[patent_app_type] => utility
[patent_app_number] => 12/652926
[patent_app_country] => US
[patent_app_date] => 2010-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14665
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0174/20100174351.pdf
[firstpage_image] =>[orig_patent_app_number] => 12652926
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/652926 | Chemically and biologically modified medical devices | Jan 5, 2010 | Issued |
Array
(
[id] => 7511377
[patent_doc_number] => 20110257087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Protein Hydrolysate Compositions Having Enhanced CCK Releasing Activity'
[patent_app_type] => utility
[patent_app_number] => 13/140939
[patent_app_country] => US
[patent_app_date] => 2009-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11988
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257087.pdf
[firstpage_image] =>[orig_patent_app_number] => 13140939
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/140939 | Protein Hydrolysate Compositions Having Enhanced CCK Releasing Activity | Dec 29, 2009 | Abandoned |
Array
(
[id] => 7669558
[patent_doc_number] => 20110318827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'Cysteine-Free Efficient Technetium (Tc) or Rhenium (Re) Chelating Peptide Tags and Their Use'
[patent_app_type] => utility
[patent_app_number] => 13/133446
[patent_app_country] => US
[patent_app_date] => 2009-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17483
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133446
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/133446 | Cysteine-free efficient Technetium (Tc) or Rhenium (Re) chelating peptide tags and their use | Dec 27, 2009 | Issued |
Array
(
[id] => 6296727
[patent_doc_number] => 20100160606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'PROCESS FOR PURIFYING A POLYMER MIXTURE'
[patent_app_type] => utility
[patent_app_number] => 12/645794
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4897
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20100160606.pdf
[firstpage_image] =>[orig_patent_app_number] => 12645794
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/645794 | Process for purifying a polymer mixture | Dec 22, 2009 | Issued |
Array
(
[id] => 10898302
[patent_doc_number] => 08921517
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-30
[patent_title] => 'Process for the production of bivalirudin'
[patent_app_type] => utility
[patent_app_number] => 13/139956
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18688
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 571
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13139956
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/139956 | Process for the production of bivalirudin | Dec 16, 2009 | Issued |
Array
(
[id] => 7766349
[patent_doc_number] => 20120034294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'METHOD OF MAKING SMALL LIPOSOMES'
[patent_app_type] => utility
[patent_app_number] => 13/140786
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4278
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034294.pdf
[firstpage_image] =>[orig_patent_app_number] => 13140786
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/140786 | METHOD OF MAKING SMALL LIPOSOMES | Dec 16, 2009 | Abandoned |
Array
(
[id] => 8278434
[patent_doc_number] => 20120172301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING ANGIOTENSIN-(1-9), DERIVATIVES THEREOF, OR A VECTOR EXPRESSING ACE2, USEFUL FOR TREATING CARDIOVASCULAR, PULMONARY, CEREBRAL, AND/OR RENAL REMODELING'
[patent_app_type] => utility
[patent_app_number] => 12/998910
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10758
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12998910
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998910 | Pharmaceutical compositions comprising angiotensin-(1-9), derivatives thereof, or a vector expressing ACE2, useful for treating cardiovascular, pulmonary, cerebral, and/or renal remodeling | Dec 14, 2009 | Issued |